← Open Payments lookup

VALERIE SHIN: Open Payments

NPI 1164906822 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,073 in 25 payments from 9 companies in 2025. Trend: 2023 $965 · 2024 $988 · 2025 $4,073

Consulting: $2,250Food & beverage: $1,246Travel & lodging: $577
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC10$3,085
Gilead Sciences, Inc.7$314
Mirum Pharmaceuticals, Inc.1$142
Madrigal Pharmaceuticals1$136
Ipsen Biopharmaceuticals, Inc2$126
Novo Nordisk Inc1$125
Tempus AI, Inc1$97
Alnylam Pharmaceuticals Inc.1$29
Intercept Pharmaceuticals, Inc.1$20

Products named: TRULANCE, Livmarli, REZDIFFRA, Wegovy, Livdelzi, XIFAXAN, IQIRVO, XT CDX.

Industry payments across CA — which companies pay providers there.